ARAY
Price
$1.38
Change
+$0.06 (+4.55%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
244.95M
48 days until earnings call
PLSE
Price
$15.07
Change
+$0.18 (+1.21%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
481.01M
39 days until earnings call
Interact to see
Advertisement

ARAY vs PLSE

Header iconARAY vs PLSE Comparison
Open Charts ARAY vs PLSEBanner chart's image
Accuray
Price$1.38
Change+$0.06 (+4.55%)
Volume$36.88K
Capitalization244.95M
Pulse Biosciences
Price$15.07
Change+$0.18 (+1.21%)
Volume$1.99K
Capitalization481.01M
ARAY vs PLSE Comparison Chart in %
Loading...
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARAY vs. PLSE commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Buy and PLSE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ARAY: $1.38 vs. PLSE: $15.08)
Brand notoriety: ARAY and PLSE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ARAY: 207% vs. PLSE: 127%
Market capitalization -- ARAY: $244.95M vs. PLSE: $481.01M
ARAY [@Medical Specialties] is valued at $244.95M. PLSE’s [@Medical Specialties] market capitalization is $481.01M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whilePLSE’s FA Score has 0 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • PLSE’s FA Score: 0 green, 5 red.
According to our system of comparison, ARAY is a better buy in the long-term than PLSE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 5 TA indicator(s) are bullish while PLSE’s TA Score has 4 bullish TA indicator(s).

  • ARAY’s TA Score: 5 bullish, 4 bearish.
  • PLSE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ARAY is a better buy in the short-term than PLSE.

Price Growth

ARAY (@Medical Specialties) experienced а +11.79% price change this week, while PLSE (@Medical Specialties) price change was -1.44% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.08%. For the same industry, the average monthly price growth was +1.35%, and the average quarterly price growth was -0.23%.

Reported Earning Dates

ARAY is expected to report earnings on Aug 14, 2025.

PLSE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+1.08% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLSE($481M) has a higher market cap than ARAY($245M). PLSE YTD gains are higher at: -13.383 vs. ARAY (-30.556). ARAY has higher annual earnings (EBITDA): 5.93M vs. PLSE (-42.37M). ARAY has more cash in the bank: 72.8M vs. PLSE (44.4M). PLSE has less debt than ARAY: PLSE (9.14M) vs ARAY (202M). ARAY has higher revenues than PLSE: ARAY (447M) vs PLSE (0).
ARAYPLSEARAY / PLSE
Capitalization245M481M51%
EBITDA5.93M-42.37M-14%
Gain YTD-30.556-13.383228%
P/E RatioN/AN/A-
Revenue447M0-
Total Cash72.8M44.4M164%
Total Debt202M9.14M2,209%
FUNDAMENTALS RATINGS
ARAY vs PLSE: Fundamental Ratings
ARAY
PLSE
OUTLOOK RATING
1..100
566
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
58
Fair valued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
8898
PRICE GROWTH RATING
1..100
8857
P/E GROWTH RATING
1..100
46100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PLSE's Valuation (58) in the Medical Specialties industry is in the same range as ARAY (86). This means that PLSE’s stock grew similarly to ARAY’s over the last 12 months.

PLSE's Profit vs Risk Rating (85) in the Medical Specialties industry is in the same range as ARAY (100). This means that PLSE’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's SMR Rating (88) in the Medical Specialties industry is in the same range as PLSE (98). This means that ARAY’s stock grew similarly to PLSE’s over the last 12 months.

PLSE's Price Growth Rating (57) in the Medical Specialties industry is in the same range as ARAY (88). This means that PLSE’s stock grew similarly to ARAY’s over the last 12 months.

ARAY's P/E Growth Rating (46) in the Medical Specialties industry is somewhat better than the same rating for PLSE (100). This means that ARAY’s stock grew somewhat faster than PLSE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYPLSE
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 19 days ago
79%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ARAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPXUX16.200.09
+0.55%
WisdomTree 500 Digital N/A
PFSZX25.34N/A
N/A
PGIM Jennison Financial Services Z
BTBFX62.50N/A
N/A
Boston Trust Asset Management
HFQRX6.99N/A
N/A
Janus Henderson Global Equity Income N
MVISX44.20N/A
N/A
Patient Opportunity IS

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with ALGN. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
+4.17%
ALGN - ARAY
46%
Loosely correlated
+0.43%
KIDS - ARAY
42%
Loosely correlated
-2.02%
NVST - ARAY
42%
Loosely correlated
+0.10%
IQV - ARAY
42%
Loosely correlated
-0.44%
ILMN - ARAY
41%
Loosely correlated
+0.67%
More

PLSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with CERS. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
+1.28%
CERS - PLSE
41%
Loosely correlated
+3.68%
IRMD - PLSE
34%
Loosely correlated
+0.12%
SMTI - PLSE
33%
Loosely correlated
+0.18%
STXS - PLSE
31%
Poorly correlated
+3.62%
ARAY - PLSE
31%
Poorly correlated
+4.17%
More